TransCode Therapeutics In... (RNAZ)
NASDAQ: RNAZ
· Real-Time Price · USD
7.13
-0.17 (-2.33%)
At close: Jun 17, 2025, 10:15 AM
TransCode Therapeutics Revenue
TransCode Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, TransCode Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
7
Market Cap
5.95M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|